Assesment of platelet antiaggregant activity of the ethanolic fraction obtained from the bark of Nectandra amazonum Nees.
DOI:
https://doi.org/10.17533/udea.vitae.v23n2a04Keywords:
Lauraceae, platelet aggregation, arachidonic acid, adenosine diphosphate, epinephrine, collagenAbstract
Background: Some species of the Lauraceae family are known to produce secondary metabolites that have antiplatelet properties. Studies on the leaves of Nectandra amazonum Nees. have shown antiaggregant activity but the bark of this species has not been studied. Objectives: To assess the antiplatelet effect of the ethanolic fraction obtained from the bark of Nectandra amazonum Nees. [N.V. “laurel amarillo”, Lauraceae] applying the “Born” turbidimetric method. Methods: The screening test compared the effects of a fraction of N. amazonum (0.1 mg/mL), acetylsalicylic acid (ASA, 0.5 mM, as reference standard) and dimethylsulphoxide (DMSO, 0.1%, as control) on human platelets stimulated with adenosine diphosphate (ADP, 2 µM), epinephrine (EPI, 1 uM (one micromolar)), collagen (COLL, 1 µg/mL) and arachidonic acid (AA, 0.2 mg/mL). Subsequently, the study focused on determining the antiaggregant potency of the N. amazonum fraction through concentration - response curves (from 1 µg/mL to 0.4 mg/mL), obtaining pIC50 (-log IC50) values against the platelet agonists. Results: Control platelets attained the highest percentage values of aggregation (96% AA, 89% EPI, 85% COLL, and 77% ADP). The N. amazonum fraction significantly reduced the aggregation effects (6% AA, 45% EPI, 10% COLL, 21% ADP), with values close to those obtained with ASA (17% AA, 21% EPI, 10% COLL, 20% ADP). According to concentration - response curves, the pIC50 values of the ethanolic fraction indicated the following order of potency: AA, 4.90 > ADP, 4.51 > COLL, 4.33 > EPI, 3.85. Conclusions: These results suggest that the N. amazonum Nees. ethanolic fraction elicited antiplatelet effects mainly related to the inhibition of the arachidonic acid pathway.
Downloads
References
WHO (2011). Global Atlas on Cardiovascular Disease Prevention and Control. Technical report, World Health Organization.
WHO (2014). Noncommunicable Diseases (NCD) Country Profiles, Colombia. Technical report, World Health Organization.
Verdier F, Fourcade L. Changes in cardiovascular risk factors in developing countries. Med Trop (Mars). 2007; 67(6):552-558.
Sudo M, Hirayama A. Treatment of anti-thrombotic therapy in coronary artery disease. Nihon Rinsho. 2014; 72(7):1276–1281.
Riccioni G, Sblendorio V. Atherosclerosis: from biology to pharmacological treatment. J Geriatr Cardiol. 2012; 9(3):305-317.
Chen C, Yang FQ, Zhang Q, Wang FQ, Hu YJ, Xia ZN. (2015). Natural products for antithrombosis. Evid Based Complement Alternat Med. 2015; 876426, 17 p.
Ballabeni V, Tognolini M, Bertoni S, Bruni R, Guerrini A, Rueda GM, Barocelli E. Antiplatelet and antithrombotic activities of essential oil from wild Ocotea quixos (Lam.) Kosterm. (Lauraceae) calices from Amazonian Ecuador. Pharmacol Res. 2007; 55(1):23-30.
Ben Amor N, Bouaziz A, Romera-Castillo C, Salido S, LinaresPalomino PJ, Bartegi A, Salido GM, Rosado JA. Characterization of the intracellular mechanisms involved in the antiaggregant properties of cinnamtannin B-1 from bay wood in human platelets. J Med Chem. 2007; 50(16):3937-3944.
Dong HP, Wu HM, Chen SJ, Chen CY. The effect of butanolides from Cinnamomum tenuifolium on platelet aggregation. Molecules. 2013; 18(10):11836-11841.
Valdés-Barrera ID, Cuca-Suarez LE, Coy-Barrera ED. Nectandra amazonum-derived flavonoids as COX-1 inhibitors: in vitro and docking studies. Nat Prod Commun. 2014; 9(5):649-652.
Coy ED, Cuca LE, Sef kow M. COX, LOX and platelet aggregation inhibitory properties of Lauraceae neolignans. Bioorg Med Chem Lett. 2009; 19(24):6922-6925.
Coy ED, Cuca LE. Three New 7.3,8.5-Connected Bicyclo[3.2.1]octanoids and Other Neolignans from Leaves of Nectandra amazonum Nees. (Lauraceae). Chem Pharm Bull. 2009; 57(6):639-642.
Vogel HG. (Ed). Drug Discovery and evaluation, Pharmacological assays, 2nd ed., Berlin Heidelberg New York: Springer Verlag; 2002. 280-282 p.
Noubiap JJ, Nansseu JR. Are the current recommendations for the use of aspirin in primary prevention of cardiovascular disease applicable in low-income countries? Vasc Health Risk Manag. 2015; 25(11):503-506.
Lalor N, Rodríguez L, Elissamburu P, Filipini E, Conde D, Nau G, Cura F, Trivi M. Clopidogrel versus prasugrel in acute coronary syndrome treated with coronary angioplasty. Medicina. 2015; 75(4):207-212
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 Vitae
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright Notice and Open Access Statement
The Journal Vitae works under the Open Access license, and the published manuscripts remain available for the public, both on the Journal's website and in databases, under the Creative Commons license, "Noncommercial Attribution" and "Share alike" systems, adopted in Colombia. Hence, when the authors agree to publish in the Journal Vitae, they will not have the right to economic retributions on publications and reproductions through different diffusion media. The documents are freely available to the internet public, permitting users to read, download, copy, distribute, print, search, or link to the full texts and pass them as data to software. The only constraint on reproduction and distribution, should be to give authors control over the integrity of their work and the right to be appropriately acknowledged and cited.
Authors declare that:
-
They are the intellectual property owners and are responsible for all the information stated in the article.
-
This manuscript has not been submitted or published in other printed or digital media. They accept the responsibility for the judgments, opinions, and points of view expressed in the published article and, therefore, they exonerate Universidad de Antioquia and Journal Vitae from any process.
-
They exempt Universidad de Antioquia and Journal Vitae from settling conflicts or disputes related to the authorship of the referred article.
-
They accept the revision of the original manuscript by suitable personnel, and they bind themselves to perform the corrections appointed or suggested by the assessors.
-
Therefore, they know the editorial process and will not bind the Editorial Board of the Journal to assume any obligations regarding the volume and issue in which the article is published.
-
They transfer the rights of publication, reprinting, and distribution of the article from the moment of its approval, in print and digital format, without the right to economic rewards, and under the licensing conditions considered relevant by Journal Vitae.
-
They fully authorize Universidad de Antioquia and Journal Vitae to submit the published material to the diverse databases and indexing systems where the Journal can be found to comply with the requirements of the regulatory authorities to maintain the national classification of journals.
-
They will assume the article publication costs established for the current issue, and they will make the payment as soon as they are informed about the volume and the issue in which the final version of the article is published.
-
After the article is published, you can share digital or printed copies in a noncommercial manner. You will be able to use the paper in your institution or company for educational or research purposes, including the use in course programs.
Conflict of interest: Authors are responsible for recognizing and disclosing any financial or other benefits that could be perceived to bias their work, acknowledging all financial support and any personal connections with potential sponsors. Examples of such conflicts include receiving research funds or honoraria, serving on advisory boards, stock ownership, or employment and consulting arrangements. Authors without such connections should clearly state that they have no financial support or personal relationships that could be perceived to bias their work. All conflicts of interest should be disclosed on the author's identification page of the manuscript.
